welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
-
Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancerAbstract A 29-year-old female visited...
-
The Natural History of Familial Adenomatous Polyposis Syndrome: A 24 Year Review of a Single Center Experience in Sc...PURPOSE : Understanding the natural hist...
-
Familial Adenomatous Polyposis (FAP): InheritedFAP is an inherited colorectal cancer sy...
-
Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal CancerExecutive Summary Colorectal Cancer con...
-
FAP & Me: A Kid’s Guide to Familial Adenomatous PolyposisFAP stands for Familial Adenomatous Poly...
-
Screening and Surveillance of the Early Detection of Colorectal Cancer and Adenomatous PolypsIn the United States, colorectal cancer ...